We are live on
!
Find out more
SI
Sapience Investments Portfolio holdings
AUM
$772K
1-Year Est. Return
24.07%
This Fund
S&P 500
This Quarter
Est. Return
+3.78%
1 Year Est. Return
+24.07%
3 Year Est. Return
+54.93%
5 Year Est. Return
+48.47%
10 Year Est. Return
–
AUM
$444M
AUM Growth
+$11.9M
(+2.7%)
Cap. Flow
+$2.78M
Cap. Flow
% of AUM
0.62%
Top 10 Holdings %
Top 10 Hldgs %
26.13%
Holding
83
New
6
Increased
21
Reduced
48
Closed
8
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
National Vision
EYE
|
+$8.46M |
| 2 |
Wintrust Financial
WTFC
|
+$7.92M |
| 3 |
ESAB
ESAB
|
+$6.33M |
| 4 |
Elanco Animal Health
ELAN
|
+$4.45M |
| 5 |
Helios Technologies
HLIO
|
+$4.28M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
AMED
Amedisys
AMED
|
+$8.13M |
| 2 |
SYNH
Syneos Health, Inc. Class A Common Stock
SYNH
|
+$6.33M |
| 3 |
Cathay General Bancorp
CATY
|
+$5.52M |
| 4 |
Valvoline
VVV
|
+$4.92M |
| 5 |
DBD
Diebold Nixdorf Incorporated
DBD
|
+$4.24M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 20.13% |
| 2 | Industrials | 18.02% |
| 3 | Consumer Discretionary | 10.68% |
| 4 | Consumer Staples | 9.97% |
| 5 | Healthcare | 9.94% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
76
Cathay General Bancorp
CATY
$4.24B
| – | – |
-159,775
| Closed | -$5.52M |
|
77
Elastic
ESTC
$7.81B
| – | – |
-11,275
| Closed | -$653K |
|
78
Genpact
G
$5.76B
| – | – |
-11,435
| Closed | -$529K |
|
79
SLM Corp
SLM
$5.15B
| – | – |
-289,190
| Closed | -$3.58M |
|
|
SNV
80
DELISTED
Synovus
SNV
| – | – |
-16,384
| Closed | -$505K |
|
|
81
Valvoline
VVV
$4.51B
| – | – |
-140,803
| Closed | -$4.92M |
|
|
SYNH
82
DELISTED
Syneos Health, Inc. Class A Common Stock
SYNH
| – | – |
-177,680
| Closed | -$6.33M |
|
|
DBD
83
DELISTED
Diebold Nixdorf Incorporated
DBD
| – | – |
-3,534,457
| Closed | -$4.24M |
|
Similar funds
HB
PA
CPIH
VS
TCI
QAM
CI
NMFM
Sapience Investments's Q2 2023 Portfolio in Review
As of Q2 2023, Sapience Investments held 83 positions worth $444M, up 2.7% from $433M the previous quarter. Its ten largest holdings account for 26% of the portfolio.
Sapience Investments's Q2 2023 filing shows 6 new, 21 increased, 48 reduced and 8 closed positions. Its largest new stake was National Vision: 363,674 shares worth $8.83M. The largest sale was Amedisys, an estimated $8.13M.
By sector, the portfolio is most concentrated in Financials at 20% of assets, down from 22% a quarter earlier, followed by Industrials and Consumer Discretionary.
- Sapience Investments's largest Q2 2023 buy was National Vision: 363,674 shares worth $8.83M.
- Sapience Investments added most to Wintrust Financial in Q2 2023, an estimated $7.92M increase.
- Sapience Investments's biggest Q2 2023 reduction was Amedisys, cutting an estimated $8.13M.
- Sapience Investments fully exited Syneos Health, Inc. Class A Common Stock in Q2 2023, selling an estimated $6.33M.
- Sapience Investments's ten largest holdings make up 26% of its $444M portfolio in Q2 2023.
- Sapience Investments opened 6 new positions and closed 8 in Q2 2023.
- Sapience Investments's portfolio value rose 2.7% quarter-over-quarter to $444M.
Based on Sapience Investments's 13F filing for Q2 2023, filed 14 Aug 2023.